HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- (p- isothiocyanatobenzyl)- 1,4,7,10,13- pentaazacyclopentadecane- N,N',N'',N''',N''''- pentaacetic acid

structure in first source

Also Known As:

BF-PEPA

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Brechbiel, M W: 1 article (05/2001)
2.	Carrasquillo, J A: 1 article (05/2001)
3.	Garmestani, K: 1 article (05/2001)
4.	Park, C W: 1 article (05/2001)
5.	Pastan, I: 1 article (05/2001)
6.	Wong, K: 1 article (05/2001)
7.	Yao, Z: 1 article (05/2001)
8.	Zhang, M: 1 article (05/2001)

Related Diseases

1.

Neoplasms (Cancer)

05/01/2001 - "The in vivo stability of the radiolabeled immunoconjugate, and targeting characteristics were determined by biodistribution studies in A431 xenograft tumor-bearing mice sacrificed at 0.5, 1, 2, 4, and 24 hr. Results indicate that BF_PEPA appears to not be a suitable bifunctional chelating agent for sequestering isotopes of Bi(III) for radioimmunotherapy applications."

Related Drugs and Biologics

1.	Immunoconjugates (Immunoconjugate)
2.	Isotopes
3.	Chelating Agents

Related Therapies and Procedures

1.	Radioimmunotherapy